Recorded: 15 Jan 2003
Well, it was quite frightening because Joe was an icon at that stage, along with Phil Sharp and they shared the same office. And I went into meet Joe and Phil for the very first time. It was entirely intimidating. I felt pretty small I must say when I met these sort of intellectual and scientific giants. I really had some second thoughts having met them as to whether I could play science in the same league as them, at that time I clearly could not. So it was a question of deciding whether I thought I had the potential to achieve something approaching their achievements and, well it’s for others to decide whether I did in hindsight, but I thought to myself at the time, unless I bite the bullet here I’m going to let a wonderful opportunity slip through my fingertips. So I embraced the opportunity, and as I’ve said, I’ve never regretted that.
Ashley Dunn is currently a Senior Consulting Scientist and member of the Scientific Advisory Board at the Cryptome Pharmaceuticals Ltd., an Australian biotech company. He also serves on Australia’s Gene Technology Advisory Committee. He is the former Head of Molecular Biology in the Melbourne Branch of the Ludwig Institute for Cancer Research.
He came to Cold Spring Harbor Laboratory in 1976 to work with Joe Sambrook as a postdoctoral fellow and eventually became a junior faculty member.
His research has been concentrated on mammalian growth factors and the regulators responsible for the production of white blood cells in mice and men. He co-invented a mammalian blood cell regulator (GM-CSF), and his lab was the one of the first to establish gene targeting in the development of human diseases such as cancer.